BioPharmX begins patient enrolment in Phase IIb OPAL study of BPX-01 to treat acne vulgaris

US-based pharmaceutical company BioPharmX has enrolled the first patient in its Phase IIb tOPicAL Minocycline Gel (OPAL) clinical trial of BPX-01 to treat acne vulgaris.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news